You just read:

IgG4-Related Disease Biomarker Development Update Presented From an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-RD at the 3rd International Symposium on IgG4-Related Diseases & Fibrosis

News provided by

Xencor, Inc.

Feb 18, 2017, 14:00 ET